Webinar | June 24, 2025

Manufacturing Considerations For Viral & Non-Viral Platform Selection

In this webinar, a panel of experts spanning the lentiviral vector (LVV), exosome and oncolytic virus fields will discuss the impact of manufacturing considerations on their respective platform selection and ongoing product/process development strategies.

Key learning points:

  • Advanced therapy technology platform selection criteria
  • Process and product development challenges and solutions at the cutting edge of the LVV, exosome, and oncolytic virotherapy fields
  • Recent and likely future evolution of viral and non-viral DSP toolkits
access the Webinar!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Thermo Fisher Scientific